748 related articles for article (PubMed ID: 15943835)
1. Overproduction of an amino-terminal form of PTH distinct from human PTH(1-84) in a case of severe primary hyperparathyroidism: influence of medical treatment and surgery.
Räkel A; Brossard JH; Patenaude JV; Albert C; Nassif E; Cantor T; Rousseau L; D'Amour P
Clin Endocrinol (Oxf); 2005 Jun; 62(6):721-7. PubMed ID: 15943835
[TBL] [Abstract][Full Text] [Related]
2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
3. Very low or undetectable intact parathyroid hormone levels in patients with surgically verified parathyroid adenomas.
Bhadada SK; Cardenas M; Bhansali A; Mittal BR; Behera A; Chanukya GV; Nahar U; Rao DS
Clin Endocrinol (Oxf); 2008 Sep; 69(3):382-5. PubMed ID: 18284640
[TBL] [Abstract][Full Text] [Related]
4. Intravenous 1,25(OH)2D therapy increases the intact parathyroid hormone secretion set point in hemodialyzed patients.
Brossard JH; Roy L; Lepage R; Gascon-Barré M; D'Amour P
Miner Electrolyte Metab; 1997; 23(1):25-32. PubMed ID: 9058366
[TBL] [Abstract][Full Text] [Related]
5. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
[TBL] [Abstract][Full Text] [Related]
6. Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity.
Nordenström E; Westerdahl J; Isaksson A; Lindblom P; Bergenfelz A
World J Surg; 2003 Feb; 27(2):212-5. PubMed ID: 12616439
[TBL] [Abstract][Full Text] [Related]
7. Elevated serum parathormone level after "concise parathyroidectomy" for primary sporadic hyperparathyroidism.
Carty SE; Roberts MM; Virji MA; Haywood L; Yim JH
Surgery; 2002 Dec; 132(6):1086-92; discussion 1092-3. PubMed ID: 12490859
[TBL] [Abstract][Full Text] [Related]
8. Immunoassays for the detection of parathyroid hormone.
Jüppner H; Potts JT
J Bone Miner Res; 2002 Nov; 17 Suppl 2():N81-6. PubMed ID: 12412782
[TBL] [Abstract][Full Text] [Related]
9. Daily follow-up of serum parathyroid hormone and calcium after surgery for primary hyperparathyroidism.
Debruyne F; Delaere P; Ostyn F; Van den Bruel A; Bouillon R
J Otolaryngol; 1999 Dec; 28(6):305-8. PubMed ID: 10604157
[TBL] [Abstract][Full Text] [Related]
10. Persistently elevated parathyroid hormone levels after parathyroid surgery.
Wang TS; Ostrower ST; Heller KS
Surgery; 2005 Dec; 138(6):1130-5; discussion 1135-6. PubMed ID: 16360400
[TBL] [Abstract][Full Text] [Related]
11. Measurement of parathyroid hormone in patients with primary hyperparathyroidism undergoing first and reoperative surgery.
Bergenfelz A; Isaksson A; Lindblom P; Westerdahl J; Tibblin S
Br J Surg; 1998 Aug; 85(8):1129-32. PubMed ID: 9718013
[TBL] [Abstract][Full Text] [Related]
12. Primary hyperparathyroidism mimicking vaso-occlusive crises in sickle cell disease.
Krishnamoorthy P; Alyaarubi S; Abish S; Gale M; Albuquerque P; Jabado N
Pediatrics; 2006 Aug; 118(2):e537-9. PubMed ID: 16882790
[TBL] [Abstract][Full Text] [Related]
13. High third generation/second generation PTH ratio in a patient with parathyroid carcinoma: clinical utility of third generation/second generation PTH ratio in patients with primary hyperparathyroidism.
Caron P; Maiza JC; Renaud C; Cormier C; Barres BH; Souberbielle JC
Clin Endocrinol (Oxf); 2009 Apr; 70(4):533-8. PubMed ID: 18782355
[TBL] [Abstract][Full Text] [Related]
14. 1,25-dihydroxyvitamin D suppresses circulating levels of parathyroid hormone in a patient with primary hyperparathyroidism and coexistent sarcoidosis.
Kinoshita Y; Taguchi M; Takeshita A; Miura D; Tomikawa S; Takeuchi Y
J Clin Endocrinol Metab; 2005 Dec; 90(12):6727-31. PubMed ID: 16159932
[TBL] [Abstract][Full Text] [Related]
15. [Primary hyperparathyroidism caused by a mediastinal adenoma with intermittent hypercalcemia and severe bone disease].
Araya AV; Pumarino H; Larenas G; Gac A
Rev Med Chil; 1992 May; 120(5):563-70. PubMed ID: 1343071
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of 1,25(OH)2D production by hypercalcemia in osteitis fibrosa cystica: influence on parathyroid hormone secretion and hungry bone disease.
Brossard JH; Garon J; Lepage R; Gascon-Barré M; D'Amour P
Bone Miner; 1993 Oct; 23(1):15-26. PubMed ID: 8274876
[TBL] [Abstract][Full Text] [Related]
17. Clinical profile of 128 subjects operated for primary hyperparathyroidism.
Haddock L; Aguiló F; Vázquez Quintana E; Vázquez MC; Rabell V; Allende M
P R Health Sci J; 1998 Dec; 17(4):309-16. PubMed ID: 10028537
[TBL] [Abstract][Full Text] [Related]
18. Effects of decreasing serum calcium on circulating parathyroid hormone and vitamin D metabolites in normocalcaemic and hypercalcaemic patients treated with APD.
Papapoulos SE; Harinck HI; Bijvoet OL; Gleed JH; Fraher LJ; O'Riordan JL
Bone Miner; 1986 Feb; 1(1):69-78. PubMed ID: 3508718
[TBL] [Abstract][Full Text] [Related]
19. Disodium pamidronate in the preoperative treatment of hypercalcemia in patients with primary hyperparathyroidism.
Jansson S; Tisell LE; Lindstedt G; Lundberg PA
Surgery; 1991 Sep; 110(3):480-6. PubMed ID: 1845370
[TBL] [Abstract][Full Text] [Related]
20. Overproduction and secretion of a novel amino-terminal form of parathyroid hormone from a severe type of parathyroid hyperplasia in uremia.
Arakawa T; D'Amour P; Rousseau L; Brossard JH; Sakai M; Kasumoto H; Igaki N; Goto T; Cantor T; Fukagawa M
Clin J Am Soc Nephrol; 2006 May; 1(3):525-31. PubMed ID: 17699255
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
